{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:54:40Z","timestamp":1792677280161,"version":"4.5.0"},"reference-count":35,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes & Infections"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/emi.2017.55","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T09:12:37Z","timestamp":1501060357000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor"],"prefix":"10.1080","volume":"6","author":[{"given":"Xueyang","family":"Zhang","sequence":"first","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Shi","sequence":"additional","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Ye","sequence":"additional","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ku","sequence":"additional","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[{"name":"Unit of Vaccinology & Antiviral Strategies, CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4161\/hv.27087","article-title":"Coxsackievirus A16: epidemiology, diagnosis, and vaccine","volume":"10","author":"Mao Q","year":"2014","unstructured":"Mao Q, Wang Y, Yao Xet al.Coxsackievirus A16: epidemiology, diagnosis, and vaccine. Hum Vaccin Immunother 2014;10: 360\u2013367.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang CY","year":"2004","unstructured":"Wang CY, Lu FL, Wu MHet al.Fatal coxsackievirus A16 infection. Pediatr Infect Dis J 2004;23: 275\u2013276.","journal-title":"Pediatr Infect Dis J"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","article-title":"Fatal infection in an infant associated with Coxsackie virus group A, type 16","volume":"268","author":"Wright Jr HT","year":"1963","unstructured":"Wright Jr HT, Landing BH, Lennette EHet al.Fatal infection in an infant associated with Coxsackie virus group A, type 16. N Engl J Med 1963;268: 1041\u20131044.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(63)80047-5","article-title":"Myocarditis possibly due to Coxsackie group A, type 16, virus","volume":"62","author":"Goldberg MF","year":"1963","unstructured":"Goldberg MF, McAdams AJ.Myocarditis possibly due to Coxsackie group A, type 16, virus. J Pediatr 1963;62: 762\u2013765.","journal-title":"J Pediatr"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu W","year":"2012","unstructured":"Xu W, Liu CF, Yan Let al.Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol J 2012;9: 8.","journal-title":"Virol J"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu Q","year":"2012","unstructured":"Liu Q, Yan K, Feng Yet al.A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge. Vaccine 2012;30: 6642\u20136648.","journal-title":"Vaccine"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai Y","year":"2013","unstructured":"Cai Y, Liu Q, Huang Xet al.Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection. Vaccine 2013;31: 2215\u20132221.","journal-title":"Vaccine"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1007\/s00253-013-5257-3","article-title":"Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice","volume":"97","author":"Zhao H","year":"2013","unstructured":"Zhao H, Li HY, Han JFet al.Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice. Appl Microbiol Biotechnol 2013;97: 10445\u201310452.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"5","key":"e_1_3_2_10_1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1099\/vir.0.063560-0","article-title":"Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates","volume":"95","author":"Li J","year":"2014","unstructured":"Li J, Chang J, Liu Xet al.Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates. J Gen Virol 2014;95 (Pt 5): 1083\u20131093.","journal-title":"J Gen Virol"},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4161\/hv.28083","article-title":"Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line","volume":"10","author":"Yang E","year":"2014","unstructured":"Yang E, Cheng C, Zhang Yet al.Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line. Hum Vaccin Immunother 2014;10: 1266\u20131273.","journal-title":"Hum Vaccin Immunother"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1006\/viro.1994.1423","article-title":"Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses","volume":"202","author":"Poyry T","year":"1994","unstructured":"Poyry T, Hyypia T, Horsnell Cet al.Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses. Virology 1994;202: 982\u2013987.","journal-title":"Virology"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JVI.07174-11","article-title":"Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses","volume":"86","author":"Lauber C","year":"2012","unstructured":"Lauber C, Gorbalenya AE.Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses. J Virol 2012;86: 3905\u20133915.","journal-title":"J Virol"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1743-422X-8-534","article-title":"Construction and characterization of an infectious clone of coxsackievirus A16","volume":"8","author":"Liu F","year":"2011","unstructured":"Liu F, Liu Q, Cai Yet al.Construction and characterization of an infectious clone of coxsackievirus A16. Virol J 2011;8: 534.","journal-title":"Virol J"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","first-page":"10500","DOI":"10.1128\/JVI.01102-15","article-title":"Structures of coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicity","volume":"89","author":"Ren J","year":"2015","unstructured":"Ren J, Wang X, Zhu Let al.Structures of coxsackievirus A16 capsids with native antigenicity: implications for particle expansion, receptor binding, and immunogenicity. J Virol 2015;89: 10500\u201310511.","journal-title":"J Virol"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/ncomms2889","article-title":"Picornavirus uncoating intermediate captured in atomic detail","volume":"4","author":"Ren JS","year":"2013","unstructured":"Ren JS, Wang XX, Hu ZYet al.Picornavirus uncoating intermediate captured in atomic detail. Nat Commun 2013;4: 1929.","journal-title":"Nat Commun"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nm.1992","article-title":"Scavenger receptor B2 is a cellular receptor for enterovirus 71","volume":"15","author":"Yamayoshi S","year":"2009","unstructured":"Yamayoshi S, Yamashita Y, Li Jet al.Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 2009;15: 798\u2013801.","journal-title":"Nat Med"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1128\/JVI.00020-12","article-title":"Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71","volume":"86","author":"Yamayoshi S","year":"2012","unstructured":"Yamayoshi S, Iizuka S, Yamashita Tet al.Human SCARB2-dependent infection by coxsackievirus A7, A14, and A16 and enterovirus 71. J Virol 2012;86: 5686\u20135696.","journal-title":"J Virol"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nm.1961","article-title":"Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71","volume":"15","author":"Nishimura Y","year":"2009","unstructured":"Nishimura Y, Shimojima M, Tano Yet al.Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 2009;15: 794\u2013797.","journal-title":"Nat Med"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1128\/JVI.75.10.4918-4921.2001","article-title":"Echoviruses bind heparan sulfate at the cell surface","volume":"75","author":"Goodfellow IG","year":"2001","unstructured":"Goodfellow IG, Sioofy AB, Powell RMet al.Echoviruses bind heparan sulfate at the cell surface. J Virol 2001;75: 4918\u20134921.","journal-title":"J Virol"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1128\/JVI.02160-06","article-title":"Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH","volume":"81","author":"Khan AG","year":"2007","unstructured":"Khan AG, Pichler J, Rosemann Aet al.Human rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH. J Virol 2007;81: 4625\u20134632.","journal-title":"J Virol"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1128\/JVI.79.10.5963-5970.2005","article-title":"Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment","volume":"79","author":"Vlasak M","year":"2005","unstructured":"Vlasak M, Goesler I, Blaas D.Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment. J Virol 2005;79: 5963\u20135970.","journal-title":"J Virol"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1128\/JVI.02226-12","article-title":"Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor","volume":"87","author":"Tan CW","year":"2013","unstructured":"Tan CW, Poh CL, Sam ICet al.Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 2013;87: 611\u2013620.","journal-title":"J Virol"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","first-page":"e1005184","DOI":"10.1371\/journal.ppat.1005184","article-title":"The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate","volume":"11","author":"Nishimura Y","year":"2015","unstructured":"Nishimura Y, McLaughlin NP, Pan Jet al.The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate. PLoS Pathog 2015;11: e1005184.","journal-title":"PLoS Pathog"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1128\/JVI.00640-12","article-title":"Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses","volume":"86","author":"McLeish NJ","year":"2012","unstructured":"McLeish NJ, Williams CH, Kaloudas Det al.Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses. J Virol 2012;86: 11163\u201311170.","journal-title":"J Virol"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.1128\/JVI.01988-05","article-title":"N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells","volume":"80","author":"Zautner AE","year":"2006","unstructured":"Zautner AE, Jahn B, Hammerschmidt Eet al.N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J Virol 2006;80: 6629\u20136636.","journal-title":"J Virol"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1128\/jvi.70.8.5282-5287.1996","article-title":"Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate","volume":"70","author":"Jackson T","year":"1996","unstructured":"Jackson T, Ellard FM, Ghazaleh RAet al.Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J Virol 1996;70: 5282\u20135287.","journal-title":"J Virol"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu Q","year":"2011","unstructured":"Liu Q, Ku Z, Cai Yet al.Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins. J Virol Methods 2011;173: 115\u2013120.","journal-title":"J Virol Methods"},{"key":"e_1_3_2_29_1","first-page":"493","article-title":"A simple method of estimating 50 percent endpoints","volume":"27","author":"Reed LJ","year":"1938","unstructured":"Reed LJ, Muench H.A simple method of estimating 50 percent endpoints. Am J Hyg 1938;27: 493\u2013499.","journal-title":"Am J Hyg"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye X","year":"2014","unstructured":"Ye X, Ku Z, Liu Qet al.Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J Virol 2014;88: 72\u201381.","journal-title":"J Virol"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku Z","year":"2013","unstructured":"Ku Z, Ye X, Huang Xet al.Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps. PLoS One 2013;8: e57601.","journal-title":"PLoS One"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1016\/j.vaccine.2014.06.025","article-title":"A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice","volume":"32","author":"Ku Z","year":"2014","unstructured":"Ku Z, Liu Q, Ye Xet al.A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Vaccine 2014;32: 4296\u20134303.","journal-title":"Vaccine"},{"issue":"5","key":"e_1_3_2_33_1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1006\/mthe.2002.0578","article-title":"Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells","volume":"5","author":"Guibinga GH","year":"2002","unstructured":"Guibinga GH, Miyanohara A, Esko JDet al.Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells. Mol Ther 2002;5 (5 Pt 1): 538\u2013546.","journal-title":"Mol Ther"},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen EL","year":"2003","unstructured":"Eskelinen EL, Tanaka Y, Saftig P.At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 2003;13: 137\u2013145.","journal-title":"Trends Cell Biol"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","first-page":"12084","DOI":"10.1128\/JVI.02189-15","article-title":"Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry","volume":"89","author":"Ku Z","year":"2015","unstructured":"Ku Z, Ye X, Shi Jet al.Single neutralizing monoclonal antibodies targeting the VP1 GH loop of enterovirus 71 inhibit both virus attachment and internalization during viral entry. J Virol 2015;89: 12084\u201312095.","journal-title":"J Virol"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.virol.2016.11.009","article-title":"VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction","volume":"501","author":"Tan CW","year":"2017","unstructured":"Tan CW, Sam IC, Lee VSet al.VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 2017;501: 79\u201387.","journal-title":"Virology"}],"container-title":["Emerging Microbes & Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1038\/emi.2017.55","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T08:25:02Z","timestamp":1695371102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1038\/emi.2017.55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1038\/emi.2017.55"],"URL":"https:\/\/doi.org\/10.1038\/emi.2017.55","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-05-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}